By Adam Bonislawski

Proteomics firms received more than $8.75 million in grants and tax credits awarded this week through the Qualifying Therapeutic Discovery Project Program, an initiative created by the Patient Protection and Affordable Care Act.

Based on the grant descriptions, a large proportion of the money, which is being provided by the Internal Revenue Service, will go toward diagnostics research, with a number of prominent proteomics-based diagnostics developers among the awardees.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.